R & D Investment Does Not Justify High Cost of Cancer Drugs R & D Investment Does Not Justify High Cost of Cancer Drugs

A new analysis found that the revenue from cancer drugs greatly exceeds the investment to develop them.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news